BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing

Reuters

13 Mar

BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing

March 13 (Reuters) - MeiraGTx Holdings PLC MGTX.O:

MEIRAGTX ENTERS INTO A STRATEGIC COLLABORATION WITH HOLOGEN AI TO EXPEDITE PHASE 3 DEVELOPMENT OF AAV-GAD FOR PARKINSON’S DISEASE AND INDUSTRIALIZE MEIRAGTX’S PROPRIETARY MANUFACTURING PROCESS
MEIRAGTX HOLDINGS PLC - TO RECEIVE $200 MILLION IN UPFRONT CASH
MEIRAGTX HOLDINGS PLC - TO RETAIN 30% OWNERSHIP IN JOINT VENTURE
MEIRAGTX HOLDINGS PLC - JOINT VENTURE HOLOGEN NEURO AI LTD TO RECEIVE $230 MILLION

Source text: ID:nGNX88BhqQ

Further company coverage: MGTX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2519479838"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2519479838\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2519479838?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-13 19:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2519479838","market":"nz","top_or_hot":-1,"title":"BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing</title></head><body><p><span>March 13 (Reuters)</span><span> - </span>MeiraGTx Holdings <a href=\"https://laohu8.com/S/PLC\">PLC</a> <span>MGTX.O</span>:</p><ul><li><p>MEIRAGTX ENTERS INTO A STRATEGIC COLLABORATION WITH HOLOGEN AI TO EXPEDITE PHASE 3 DEVELOPMENT OF AAV-GAD FOR PARKINSON’S DISEASE AND INDUSTRIALIZE MEIRAGTX’S PROPRIETARY MANUFACTURING PROCESS</p></li><li><p>MEIRAGTX HOLDINGS PLC - TO RECEIVE $200 MILLION IN UPFRONT CASH</p></li><li><p>MEIRAGTX HOLDINGS PLC - TO RETAIN 30% OWNERSHIP IN JOINT VENTURE</p></li><li><p>MEIRAGTX HOLDINGS PLC - JOINT VENTURE HOLOGEN NEURO AI LTD TO RECEIVE $230 MILLION</p></li></ul><p>Source text: <span>ID:nGNX88BhqQ</span></p><p>Further company coverage: <span>MGTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-13 19:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing</title></head><body><p><span>March 13 (Reuters)</span><span> - </span>MeiraGTx Holdings <a href=\"https://laohu8.com/S/PLC\">PLC</a> <span>MGTX.O</span>:</p><ul><li><p>MEIRAGTX ENTERS INTO A STRATEGIC COLLABORATION WITH HOLOGEN AI TO EXPEDITE PHASE 3 DEVELOPMENT OF AAV-GAD FOR PARKINSON’S DISEASE AND INDUSTRIALIZE MEIRAGTX’S PROPRIETARY MANUFACTURING PROCESS</p></li><li><p>MEIRAGTX HOLDINGS PLC - TO RECEIVE $200 MILLION IN UPFRONT CASH</p></li><li><p>MEIRAGTX HOLDINGS PLC - TO RETAIN 30% OWNERSHIP IN JOINT VENTURE</p></li><li><p>MEIRAGTX HOLDINGS PLC - JOINT VENTURE HOLOGEN NEURO AI LTD TO RECEIVE $230 MILLION</p></li></ul><p>Source text: <span>ID:nGNX88BhqQ</span></p><p>Further company coverage: <span>MGTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MGTX","symbol_name":"Meiragtx Holdings Plc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUAPX6JD:1","article_id":"2519479838","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2519479838","pubTimestamp":1741865892,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturingMarch 13 (Reuters) - MeiraGTx Holdings PLC MGTX.O:MEIRAGTX ENTERS INTO A ST","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MGTX":"Meiragtx Holdings Plc","BK4139":"生物科技"},"translate_title":"简介-MeiraGTx与Hologen AI合作加快帕金森病疗法的开发并扩大生产规模","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MGTX":0.9},"content_text":"BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturingMarch 13 (Reuters) - MeiraGTx Holdings PLC MGTX.O:MEIRAGTX ENTERS INTO A STRATEGIC COLLABORATION WITH HOLOGEN AI TO EXPEDITE PHASE 3 DEVELOPMENT OF AAV-GAD FOR PARKINSON’S DISEASE AND INDUSTRIALIZE MEIRAGTX’S PROPRIETARY MANUFACTURING PROCESSMEIRAGTX HOLDINGS PLC - TO RECEIVE $200 MILLION IN UPFRONT CASHMEIRAGTX HOLDINGS PLC - TO RETAIN 30% OWNERSHIP IN JOINT VENTUREMEIRAGTX HOLDINGS PLC - JOINT VENTURE HOLOGEN NEURO AI LTD TO RECEIVE $230 MILLIONSource text: ID:nGNX88BhqQFurther company coverage: MGTX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}